Literature DB >> 19273158

Cognition in multiple sclerosis: a review of neuropsychological and fMRI research.

Helen M Genova1, James F Sumowski, Nancy Chiaravalloti, Gerald T Voelbel, John Deluca.   

Abstract

Multiple Sclerosis (MS) is a disease of the central nervous system affecting millions of people worldwide. In addition to the disabling physical symptoms of MS, roughly 65% of individuals with MS also experience significant cognitive dysfunction, especially in the domains of learning/memory, processing speed (PS) and working memory (WM). The purpose of this review is to examine major topics in research on cognitive dysfunction, as well as review recent functional magnetic resonance imaging (fMRI) studies focusing on cognitive dysfunction in MS. Additionally, directions for future research are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19273158     DOI: 10.2741/3336

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  12 in total

1.  Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.

Authors:  Nicholas A Hubbard; Monroe Turner; Joanna L Hutchison; Austin Ouyang; Jeremy Strain; Larry Oasay; Saranya Sundaram; Scott Davis; Gina Remington; Ryan Brigante; Hao Huang; John Hart; Teresa Frohman; Elliot Frohman; Bharat B Biswal; Bart Rypma
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-09       Impact factor: 6.200

2.  Deconstructing spatial working memory and attention deficits in multiple sclerosis.

Authors:  Leon Gmeindl; Susan M Courtney
Journal:  Neuropsychology       Date:  2011-11-07       Impact factor: 3.295

3.  Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2010-03-05       Impact factor: 6.312

4.  Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.

Authors:  Francesco Mori; Silvia Rossi; Giulia Sancesario; Claudia Codecà; Giorgia Mataluni; Fabrizia Monteleone; Fabio Buttari; Hajime Kusayanagi; Maura Castelli; Caterina Motta; Valeria Studer; Giorgio Bernardi; Giacomo Koch; Sergio Bernardini; Diego Centonze
Journal:  Neuropsychopharmacology       Date:  2010-10-13       Impact factor: 7.853

5.  Processing speed versus working memory: contributions to an information-processing task in multiple sclerosis.

Authors:  Helen M Genova; Jeannie Lengenfelder; Nancy D Chiaravalloti; Nancy B Moore; John DeLuca
Journal:  Appl Neuropsychol Adult       Date:  2012       Impact factor: 2.248

Review 6.  Neurodegenerative disorders and nanoformulated drug development.

Authors:  Ari Nowacek; Lisa M Kosloski; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

7.  The relationship between executive functioning, processing speed, and white matter integrity in multiple sclerosis.

Authors:  Helen M Genova; John DeLuca; Nancy Chiaravalloti; Glenn Wylie
Journal:  J Clin Exp Neuropsychol       Date:  2013-06-18       Impact factor: 2.475

Review 8.  Myelin, copper, and the cuprizone model of schizophrenia.

Authors:  Nicole R Herring; Christine Konradi
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

9.  Evaluation of Visual-Evoked Cerebral Metabolic Rate of Oxygen as a Diagnostic Marker in Multiple Sclerosis.

Authors:  Nicholas A Hubbard; Yoel Sanchez Araujo; Camila Caballero; Minhui Ouyang; Monroe P Turner; Lyndahl Himes; Shawheen Faghihahmadabadi; Binu P Thomas; John Hart; Hao Huang; Darin T Okuda; Bart Rypma
Journal:  Brain Sci       Date:  2017-06-11

10.  Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.

Authors:  Maria Engström; Gullvi Flensner; Anne-Marie Landtblom; Anna-Christina Ek; Thomas Karlsson
Journal:  Brain Behav       Date:  2013-10-11       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.